SLC6A1 and attention deficit-hyperactivity disorder: The clinical phenotype associated with SLC6A1 pathogenic variants includes epilepsy with various seizure types (absences, myoclonic, atonic, and tonic–clonic seizures), neurodevelopmental disorders (i.e., ASD and ADHD), and psychiatric features affecting mood and behavior (i.e., aggressivity and anxiety).